// App-Quantinova.ai

: Imaging neurodegeneration markers are associated with multiple pathophysiological mechanisms in the early stages of the Alzheimer’s continuum

Researchers

Presenter

  • Gemma Salvadó

Principal Investigators

  • Mahnaz Shekari

  • Marta Milà-Alomà

  • Gonzalo Sánchez-Benavides

  • Greg Operto

  • Carles Falcon

  • Raffaele Cacciaglia

  • Aida Niñerola-Baizán

  • Andrés Perissinotti

  • Carolina Minguillón

  • Karine Fauria

  • Gwendlyn Kollmorgen

  • Ivonne Suridjan

  • Jose Molinuevo

  • Henrik Zetterberg

  • Kaj Blennow

  • Marc Suárez-Calvet

  • Juan Domingo Gispert

Medical Centers

  • Hospital del Mar Medical Research Insitute (IMIM)

  • Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)

  • Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation

  • *Current Address: H. Lundbeck A/S

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Servei de Neurologia, Hospital del Mar

  • Hospital Clinic,

  • Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES)

  • Universitat Pompeu Fabra,

  • Roche Diagnostics International AG

  • UK Dementia Research Institute

  • Institute of Physiology and Neuroscience, University of Gothenburg

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

Locations

  • Venezuela

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved